home / stock / tlt:cc / tlt:cc news

TLT:CC News and Press, Theralase Technologies Inc. From 09/24/25

Stock Information
Company Name: Theralase Technologies Inc.
Stock Symbol: TLT:CC
Market: TSXVC
Website: theralase.com
Menu
TLT:CC TLT:CC Quote TLT:CC Short TLT:CC News TLT:CC Articles TLT:CC Message Board
Get TLT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
TLT:CC - Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase ® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase ® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment ...
TLT:CC - Theralase(R) Releases 2Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer,...

TLT:CC - Expected Canadian Company Earnings on Monday, August 25th, 2025

Blockmint Technologies Inc. (BKMT:CA) is expected to report for Q2 2025 Endurance Gold Corporation (EDG:CA) is expected to report for Q2 2025 Golconda Gold Ltd. (GG:CA) is expected to report for Q2 2025 G2 Goldfields Inc. (GTWO:CA) is expected to report $0 for Q4 2025 Urbanfund Co...

TLT:CC - Expected Canadian Company Earnings on Monday, August 11th, 2025

Batero Gold Corp. (BAT:CA) is expected to report for quarter end 2025-05-31 Ballard Power Systems Inc. (BLDP:CA) is expected to report $-0.14 for Q2 2025 Verisante Technology Inc. (VER.H:CA) is expected to report for Q2 2025 Tvi Pacific Inc. (TVI:CA) is expected to report for Q2 2025 ...
TLT:CC - Theralase Completes Annual General and Special Meeting

Toronto, Ontario--(Newsfile Corp. - June 12, 2025) -  Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of ...

TLT:CC - Theralase Annual General Meeting

Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bact...

TLT:CC - Theralase(R) 1Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. ( TSXV: TLT ) ( OTCQB: TLTFF ) (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, ba...
TLT:CC - CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025

Radiation-Activated Rutherrin(R) Versus Radiation Alone in Preclinical Cancer Models to be Presented at ASTRO 2025 This Press Release removes references to preclinical data that has not yet been presented. Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc.&#...

TLT:CC - Expected Canadian Company Earnings on Thursday, May 29th, 2025

Grid Metals Corp. (GRDM:CA) is expected to report for quarter end 2025-03-31 Canadian Imperial Bank Of Commerce (CM:CA) is expected to report $1.87 for Q2 2025 NorthStar Gaming Holdings Inc. (BET:CA) is expected to report for quarter end 2025-03-31 Mapath Capital Corp. (MPTH.H:CA) is ...

TLT:CC - Theralase to Present Groundbreaking Research at ASTRO 2025

Radiation-Activated Rutherrin(R) Shown to Be 100 Times More Effective Than Radiation Alone in Preclinical Cancer Models Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage ph...
Previous 10 Next 10